109 related articles for article (PubMed ID: 20520626)
41. cis-Urocanic acid does not inhibit mitogen induced lymphocyte transformation in man.
Higaki Y; Hauser C; Siegenthaler G; Saurat JH
Acta Derm Venereol; 1986; 66(6):523-6. PubMed ID: 2433874
[TBL] [Abstract][Full Text] [Related]
42. Antitumor effect of chondroitin AC lyase (PsPL8A) from Pedobacter saltans on melanoma and fibrosarcoma cell lines by in vitro analysis.
Rani A; Rajulapati V; Goyal A
Pharmacol Rep; 2019 Feb; 71(1):167-174. PubMed ID: 30550997
[TBL] [Abstract][Full Text] [Related]
43. Characterization of a monoclonal antibody to cis-urocanic acid: detection of cis-urocanic acid in the serum of irradiated mice by immunoassay.
Moodycliffe AM; Norval M; Kimber I; Simpson TJ
Immunology; 1993 Aug; 79(4):667-72. PubMed ID: 8406594
[TBL] [Abstract][Full Text] [Related]
44. cis-Urocanic acid initiates gene transcription in primary human keratinocytes.
Kaneko K; Smetana-Just U; Matsui M; Young AR; John S; Norval M; Walker SL
J Immunol; 2008 Jul; 181(1):217-24. PubMed ID: 18566387
[TBL] [Abstract][Full Text] [Related]
45. Differential effects of a monoclonal antibody to cis-urocanic acid on the suppression of delayed and contact hypersensitivity following ultraviolet irradiation.
Moodycliffe AM; Bucana CD; Kripke ML; Norval M; Ullrich SE
J Immunol; 1996 Oct; 157(7):2891-9. PubMed ID: 8816394
[TBL] [Abstract][Full Text] [Related]
46. Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways.
Wu J; Xu J; Eksioglu EA; Chen X; Zhou J; Fortenbery N; Wei S; Dong J
Nutr Cancer; 2013; 65(1):110-7. PubMed ID: 23368920
[TBL] [Abstract][Full Text] [Related]
47. Screening of urocanic acid isomers in human basal and squamous cell carcinoma tumors compared with tumor periphery and healthy skin.
Decara JM; Aguilera J; Abdala R; Sánchez P; Figueroa FL; Herrera E
Exp Dermatol; 2008 Oct; 17(10):806-12. PubMed ID: 18312386
[TBL] [Abstract][Full Text] [Related]
48. The in-vitro and in-vivo inhibitory activity of biflorin in melanoma.
Vasconcellos MC; Bezerra DP; Fonseca AM; Araújo AJ; Pessoa C; Lemos TL; Costa-Lotufo LV; de Moraes MO; Montenegro RC
Melanoma Res; 2011 Apr; 21(2):106-14. PubMed ID: 21346641
[TBL] [Abstract][Full Text] [Related]
49. Manipulating tumor acidification as a cancer treatment strategy.
McCarty MF; Whitaker J
Altern Med Rev; 2010 Sep; 15(3):264-72. PubMed ID: 21155627
[TBL] [Abstract][Full Text] [Related]
50. Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway.
Ying TH; Yang SF; Tsai SJ; Hsieh SC; Huang YC; Bau DT; Hsieh YH
Arch Toxicol; 2012 Feb; 86(2):263-73. PubMed ID: 21964635
[TBL] [Abstract][Full Text] [Related]
51. Urocanic acid as an immunosuppressant in allotransplantation in mice.
Guymer RH; Mandel TE
Transplantation; 1993 Jan; 55(1):36-43. PubMed ID: 8420062
[TBL] [Abstract][Full Text] [Related]
52. Preclinical evaluation of the antimetastatic efficacy of Pentoxifylline on A375 human melanoma cell line.
Kamran MZ; Gude RP
Biomed Pharmacother; 2012 Dec; 66(8):617-26. PubMed ID: 23089470
[TBL] [Abstract][Full Text] [Related]
53. Urocanic acid isomers in patients with non-melanoma skin cancer.
De Simone C; Masini C; Cattaruzza MS; Guerriero C; Cerimele D; Norval M
Br J Dermatol; 2001 Apr; 144(4):858-61. PubMed ID: 11298549
[TBL] [Abstract][Full Text] [Related]
54. Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin.
Nath K; Nelson DS; Heitjan DF; Leeper DB; Zhou R; Glickson JD
NMR Biomed; 2015 Mar; 28(3):281-90. PubMed ID: 25504852
[TBL] [Abstract][Full Text] [Related]
55. The Multiple Roles of Urocanic Acid in Health and Disease.
Hart PH; Norval M
J Invest Dermatol; 2021 Mar; 141(3):496-502. PubMed ID: 32919759
[TBL] [Abstract][Full Text] [Related]
56. In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: evaluation of antiproliferative activity and apoptosis induction.
Salomone B; Ponti R; Gasco MR; Ugazio E; Quaglino P; Osella-Abate S; Bernengo MG
Clin Exp Metastasis; 2000; 18(8):663-73. PubMed ID: 11827070
[TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo evaluation of resveratrol and 3,5-dihydroxy-4'-acetoxy-trans-stilbene in the treatment of human prostate carcinoma and melanoma.
Osmond GW; Masko EM; Tyler DS; Freedland SJ; Pizzo S
J Surg Res; 2013 Jan; 179(1):e141-8. PubMed ID: 22482756
[TBL] [Abstract][Full Text] [Related]
58. Extracellular acidification by lactic acid suppresses glucose deprivation-induced cell death and autophagy in B16 melanoma cells.
Matsuo T; Sadzuka Y
Biochem Biophys Res Commun; 2018 Feb; 496(4):1357-1361. PubMed ID: 29421654
[TBL] [Abstract][Full Text] [Related]
59. Antiproliferative Activity of Mycalin A and Its Analogues on Human Skin Melanoma and Human Cervical Cancer Cells.
Capasso D; Borbone N; Terracciano M; Di Gaetano S; Piccialli V
Mar Drugs; 2020 Jul; 18(8):. PubMed ID: 32751383
[TBL] [Abstract][Full Text] [Related]
60. Dickkopf-1 activates cell death in MDA-MB435 melanoma cells.
Mikheev AM; Mikheeva SA; Rostomily R; Zarbl H
Biochem Biophys Res Commun; 2007 Jan; 352(3):675-80. PubMed ID: 17141200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
